Patent Yard Sign in
Expired Canadian patentCanada

Recombinant defective adenoviruses expressing cytokines for an antitumoral treatment

CA 2102302 C · Owner: Ragot, Thierry · Inventors: Haddada, Hedi; Perricaudet, Michel; Ragot, Thierry

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 16, 1993 and granted May 20, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 16, 2013.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 16, 2015.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 16, 1993
GrantedMay 20, 2003
Term endedMarch 16, 2013
Patent numberCA 2102302 C
Classification (IPC)C12N15/86 +2 more

Timeline

Timeline From CIPO dates

1994199619982000200220042006200820102012Application filedMarch 16, 1993Patent grantedMay 20, 2003Term endedMarch 16, 2013

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.